USPTO serial 79336458
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles Ho
Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Immunostimulants; nutraceutical preparations for therapeutic and medical purposes for use as a dietary supplement; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of autoimmune diseases, cancer and tumor; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic preparations for medical purposes; stem cells for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic preparations for veterinary purposes; blood products for medical purposes, namely, blood plasma and blood for medical purposes | ACTIVE | — |
| 042 | Technological research in the field of genome editing, pharmaceuticals, clinical medicine and biochemistry; conducting technical project studies, namely, conducting technical research in the field of medical and pharmaceutical studies; research and development of new products for others; scientific laboratory services; scientific research; quality inspection in the nature of product quality evaluation; product quality evaluation; quality system certification services, namely, providing quality assurance services in the field of genome editing and pharmaceuticals to determine conformity with certification standards; quality control for others; biological research; scientific research in the nature of conducting clinical trials for others | ACTIVE | — |
| 044 | Nursing, medical; pharmaceutical consulting; therapy services being medical services, namely, stem cell therapy services, somatic cell therapy services, cancer therapy services, genetic disease therapy services, inflammation therapy services and immunotherapy services; alternative medicine services; human tissue bank services; animal breeding; veterinary assistance in the nature of veterinary testing for diagnostic and treatment purposes; medical clinic services; hospital services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 31, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 5, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 5, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 25, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 13, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 13, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 7, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 3, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 20, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 19, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 24, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |